Report Detail

Pharma & Healthcare Global Kidney Cancer Drugs Market Professional Survey Report 2019

  • RnM3720452
  • |
  • 03 September, 2019
  • |
  • Global
  • |
  • 128 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) of the renal pelvis. These names reflect the type of cell from which the cancer developed. The different types of kidney cancer (such as RCC and TCC) develop in different ways, meaning that the diseases have different long term outcomes, and need to be staged and treated in different ways. RCC is responsible for approximately 80% of primary renal cancers, and TCC accounts the majority of the remainder.
Biological therapies are drugs which are used to kill cancer cells or stop them from growing. Biological therapies are used to try to shrink or control advanced kidney cancer and help people to live longer. You may be given biological therapies for kidney cancer that has already spread, or is at high-risk of coming back after surgery.

The global Kidney Cancer Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Kidney Cancer Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Kidney Cancer Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Kidney Cancer Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Kidney Cancer Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bayer
Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics
ArQule
AVEO Pharmaceuticals
Bionomics
Bristol-Myers Squibb
Cerulean Pharma
Exelixis
Genentech
immatics biotechnologies
Immunicum
Ono Pharmaceutical
Onyx Therapeutics
Oxford BioMedica
Prometheus Laboratories
Seattle Genetics
Taiwan Liposome
Tracon Pharmaceuticals
Wilex

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)

Segment by Application
Renal cell carcinoma (RCC)
Transitional cell carcinoma (TCC)


Table of Contents

    Executive Summary

      1 Industry Overview of Kidney Cancer Drugs

      • 1.1 Definition of Kidney Cancer Drugs
      • 1.2 Kidney Cancer Drugs Segment by Type
        • 1.2.1 Global Kidney Cancer Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Angiogenesis Inhibitors
        • 1.2.3 mTOR Inhibitors
        • 1.2.4 Monoclonal Antibodies
        • 1.2.5 Cytokine Immunotherapy (IL-2)
      • 1.3 Kidney Cancer Drugs Segment by Applications
        • 1.3.1 Global Kidney Cancer Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Renal cell carcinoma (RCC)
        • 1.3.3 Transitional cell carcinoma (TCC)
      • 1.4 Global Kidney Cancer Drugs Overall Market
        • 1.4.1 Global Kidney Cancer Drugs Revenue (2014-2025)
        • 1.4.2 Global Kidney Cancer Drugs Production (2014-2025)
        • 1.4.3 North America Kidney Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Kidney Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Kidney Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Kidney Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Kidney Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Kidney Cancer Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Kidney Cancer Drugs
      • 2.3 Manufacturing Process Analysis of Kidney Cancer Drugs
      • 2.4 Industry Chain Structure of Kidney Cancer Drugs

      3 Development and Manufacturing Plants Analysis of Kidney Cancer Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Kidney Cancer Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Kidney Cancer Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Kidney Cancer Drugs Production and Capacity Analysis
      • 4.2 Kidney Cancer Drugs Revenue Analysis
      • 4.3 Kidney Cancer Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Kidney Cancer Drugs Regional Market Analysis

      • 5.1 Kidney Cancer Drugs Production by Regions
        • 5.1.1 Global Kidney Cancer Drugs Production by Regions
        • 5.1.2 Global Kidney Cancer Drugs Revenue by Regions
      • 5.2 Kidney Cancer Drugs Consumption by Regions
      • 5.3 North America Kidney Cancer Drugs Market Analysis
        • 5.3.1 North America Kidney Cancer Drugs Production
        • 5.3.2 North America Kidney Cancer Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Kidney Cancer Drugs Import and Export
      • 5.4 Europe Kidney Cancer Drugs Market Analysis
        • 5.4.1 Europe Kidney Cancer Drugs Production
        • 5.4.2 Europe Kidney Cancer Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Kidney Cancer Drugs Import and Export
      • 5.5 China Kidney Cancer Drugs Market Analysis
        • 5.5.1 China Kidney Cancer Drugs Production
        • 5.5.2 China Kidney Cancer Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Kidney Cancer Drugs Import and Export
      • 5.6 Japan Kidney Cancer Drugs Market Analysis
        • 5.6.1 Japan Kidney Cancer Drugs Production
        • 5.6.2 Japan Kidney Cancer Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Kidney Cancer Drugs Import and Export
      • 5.7 Southeast Asia Kidney Cancer Drugs Market Analysis
        • 5.7.1 Southeast Asia Kidney Cancer Drugs Production
        • 5.7.2 Southeast Asia Kidney Cancer Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Kidney Cancer Drugs Import and Export
      • 5.8 India Kidney Cancer Drugs Market Analysis
        • 5.8.1 India Kidney Cancer Drugs Production
        • 5.8.2 India Kidney Cancer Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Kidney Cancer Drugs Import and Export

      6 Kidney Cancer Drugs Segment Market Analysis (by Type)

      • 6.1 Global Kidney Cancer Drugs Production by Type
      • 6.2 Global Kidney Cancer Drugs Revenue by Type
      • 6.3 Kidney Cancer Drugs Price by Type

      7 Kidney Cancer Drugs Segment Market Analysis (by Application)

      • 7.1 Global Kidney Cancer Drugs Consumption by Application
      • 7.2 Global Kidney Cancer Drugs Consumption Market Share by Application (2014-2019)

      8 Kidney Cancer Drugs Major Manufacturers Analysis

      • 8.1 Bayer
        • 8.1.1 Bayer Kidney Cancer Drugs Production Sites and Area Served
        • 8.1.2 Bayer Product Introduction, Application and Specification
        • 8.1.3 Bayer Kidney Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Roche
        • 8.2.1 Roche Kidney Cancer Drugs Production Sites and Area Served
        • 8.2.2 Roche Product Introduction, Application and Specification
        • 8.2.3 Roche Kidney Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 GlaxoSmithKline
        • 8.3.1 GlaxoSmithKline Kidney Cancer Drugs Production Sites and Area Served
        • 8.3.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.3.3 GlaxoSmithKline Kidney Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Novartis
        • 8.4.1 Novartis Kidney Cancer Drugs Production Sites and Area Served
        • 8.4.2 Novartis Product Introduction, Application and Specification
        • 8.4.3 Novartis Kidney Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Pfizer
        • 8.5.1 Pfizer Kidney Cancer Drugs Production Sites and Area Served
        • 8.5.2 Pfizer Product Introduction, Application and Specification
        • 8.5.3 Pfizer Kidney Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Abbott Laboratories
        • 8.6.1 Abbott Laboratories Kidney Cancer Drugs Production Sites and Area Served
        • 8.6.2 Abbott Laboratories Product Introduction, Application and Specification
        • 8.6.3 Abbott Laboratories Kidney Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Active Biotech
        • 8.7.1 Active Biotech Kidney Cancer Drugs Production Sites and Area Served
        • 8.7.2 Active Biotech Product Introduction, Application and Specification
        • 8.7.3 Active Biotech Kidney Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Amgen
        • 8.8.1 Amgen Kidney Cancer Drugs Production Sites and Area Served
        • 8.8.2 Amgen Product Introduction, Application and Specification
        • 8.8.3 Amgen Kidney Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Argos Therapeutics
        • 8.9.1 Argos Therapeutics Kidney Cancer Drugs Production Sites and Area Served
        • 8.9.2 Argos Therapeutics Product Introduction, Application and Specification
        • 8.9.3 Argos Therapeutics Kidney Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 ArQule
        • 8.10.1 ArQule Kidney Cancer Drugs Production Sites and Area Served
        • 8.10.2 ArQule Product Introduction, Application and Specification
        • 8.10.3 ArQule Kidney Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 AVEO Pharmaceuticals
      • 8.12 Bionomics
      • 8.13 Bristol-Myers Squibb
      • 8.14 Cerulean Pharma
      • 8.15 Exelixis
      • 8.16 Genentech
      • 8.17 immatics biotechnologies
      • 8.18 Immunicum
      • 8.19 Ono Pharmaceutical
      • 8.20 Onyx Therapeutics
      • 8.21 Oxford BioMedica
      • 8.22 Prometheus Laboratories
      • 8.23 Seattle Genetics
      • 8.24 Taiwan Liposome
      • 8.25 Tracon Pharmaceuticals
      • 8.26 Wilex

      9 Development Trend of Analysis of Kidney Cancer Drugs Market

      • 9.1 Global Kidney Cancer Drugs Market Trend Analysis
        • 9.1.1 Global Kidney Cancer Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Kidney Cancer Drugs Regional Market Trend
        • 9.2.1 North America Kidney Cancer Drugs Forecast 2019-2025
        • 9.2.2 Europe Kidney Cancer Drugs Forecast 2019-2025
        • 9.2.3 China Kidney Cancer Drugs Forecast 2019-2025
        • 9.2.4 Japan Kidney Cancer Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Kidney Cancer Drugs Forecast 2019-2025
        • 9.2.6 India Kidney Cancer Drugs Forecast 2019-2025
      • 9.3 Kidney Cancer Drugs Market Trend (Product Type)
      • 9.4 Kidney Cancer Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Kidney Cancer Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Kidney Cancer Drugs. Industry analysis & Market Report on Kidney Cancer Drugs is a syndicated market report, published as Global Kidney Cancer Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Kidney Cancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,772.00
        4,158.00
        5,544.00
        3,234.00
        4,851.00
        6,468.00
        529,515.00
        794,272.50
        1,059,030.00
        291,795.00
        437,692.50
        583,590.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report